EUVIMEDEUVIMED entdecken
Crossref

Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple Therapy

Yasutaka Yamada, Tomoki Shirafuji, Kodai Sato, Takuya Tsujino, Satoshi Yamamoto, Takayuki Arai, Hiroaki Sato, Kosuke Higuchi, Manato Kanesaka, Nobushige Takeshita, Takaaki Tamura, Tomokazu Sazuka und 8 weitere

Anticancer Research · 2026

DOI: 10.21873/anticanres.18013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Yasutaka Yamada und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan; yasutaka_yamada@chiba-u.jp. Hauptthemen laut MEDLINE: Docetaxel, Prostatic Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Febrile Neutropenia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aim: Triplet therapy, combining androgen deprivation therapy (ADT), darolutamide, and docetaxel has recently emerged as the standard first-line treatment for metastatic hormone-sensitive prostate cancer (mHSPC). Febrile neutropenia (FN) is a major clinical issue not only as a serious infection but also as a cause for early cessation or dose reduction of chemotherapy. However, little is known regarding the predictive factors for the development of FN in patients with mHSPC receiving triplet therapy. Patients and Methods: This study enrolled 60 patients diagnosed with mHSPC across multiple institutions from 2023 to 2025. We examined clinical characteristics, treatment schedules, adverse events, and oncological outcomes. We focused particularly on the development of FN and used logistic regression analysis to investigate the predictive factors. Results: The median age was 72 years old, and 43 patients (73.3%) had high-volume disease at diagnosis. Nine patients (15%) developed FN. Multivariate logistic regression analysis identified older age [≥75, p=0.0161; hazard ratio (HR)=7.49], high-volume disease (p=0.0335), and shorter interval from ADT to docetaxel (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DocetaxelProstatic NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsFebrile NeutropeniaOrchiectomyHumansMaleAgedAged, 80 and overMiddle AgedAndrogen AntagonistsNeoplasm Metastasis

Stichwörter der Autor:innen

Prostate cancerdocetaxelfebrile neutropeniametastatic hormone-sensitive prostate cancertriplet therapy

Substanzen

DocetaxelAndrogen Antagonists

Autor:innen und Institutionen

  • Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan; yasutaka_yamada@chiba-u.jp.
  • Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Department of Urology, Kimitsu Chuo Byoin, Chiba, Japan.
  • Department of Urology, Chiba Rosai Hospital, Chiba, Japan.
  • Department of Urology, Chibaken Saiseikai Narashino Hospital, Chiba, Japan.

Zitieren

APA

Yamada, Y., Shirafuji, T., Sato, K., Tsujino, T., Yamamoto, S., Arai, T., Sato, H., Higuchi, K., Kanesaka, M., Takeshita, N., Tamura, T., Sazuka, T., Imamura, Y., Mikami, K., Nakamura, K., Fukasawa, S., Kurozumi, A., Suzuki, N., Azuma, H., & Sakamoto, S. (2026). Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple Therapy. Anticancer Research. https://doi.org/10.21873/anticanres.18013

Vancouver

Yamada Y, Shirafuji T, Sato K, Tsujino T, Yamamoto S, Arai T, et al. Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple Therapy. Anticancer Research. 2026. doi:10.21873/anticanres.18013

BibTeX
@article{Yamada2026,
  author = {Yamada, Yasutaka and Shirafuji, Tomoki and Sato, Kodai and Tsujino, Takuya and Yamamoto, Satoshi and Arai, Takayuki and Sato, Hiroaki and Higuchi, Kosuke and Kanesaka, Manato and Takeshita, Nobushige and Tamura, Takaaki and Sazuka, Tomokazu and Imamura, Yusuke and Mikami, Kazuo and Nakamura, Kazuyoshi and Fukasawa, Satoshi and Kurozumi, Akira and Suzuki, Noriyuki and Azuma, Haruhito and Sakamoto, Shinichi},
  title = {Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple Therapy},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18013}
}
Kostenlos starten →